Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Will Truvada, as a prophylactic, have applications in

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
oc631 Member Profile
Member Level 
Followed By 12
Posts 1,652
Boards Moderated 0
Alias Born 08/12/07
160x600 placeholder
Impasse Puts Chill on Greek Business
If Prime Minister Antonis Samaras and his ruling New Democracy party aren't able to win the vote in one of three tries this month, Parliament would be dissolved and national elections called. Lawmakers failed to elect a president last week in the first round of voting. A second parliamentary vote takes place this week and the last is tentatively scheduled for Dec. 29.
Deezer Names New CEO Before Full U.S. Launch
Whistleblowers Score a Big Payday -- Update
Mobile's Rise Poses a Riddle for Banks
AT&T Boosts Dividend
Brazilian Shares Rise, Led by Rossi Residencial; Real Weakens Slightly
U.S. Hot Stocks: Hot Stocks to Watch
Oracle Beats Street View for First Time in a Year
Alstom CEO Expects to Settle DOJ Bribery Allegations Very Soon
Suspect in Shooting of New York Officers Had Troubled History -- 2nd Update
oc631 Member Level  Saturday, 05/12/12 03:34:19 PM
Re: bladerunner1717 post# 141855
Post # of 184966 
Quote:
Will Truvada, as a prophylactic, have applications in the Third World, especially Africa? Wouldn't the Gates Foundation and WHO want to get involved with this drug?





Truvada prophylaxis testing was first done using prostitutes in Africa. Outside of cost there would be problems with user compliance in third world countries.

Prophylaxis seems like a good idea when demonstrated in a controlled environment, not in the third world. User compliance will be difficult even here in the U.S.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist